Mirtti T - Search Results

1

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.

Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T, Yu T, Bot BM, Shen L, Abdallah K, Norman T, Friend S, Stolovitzky G, Soule H, Sweeney CJ, Ryan CJ, Scher HI, Sartor O, Xie Y, Aittokallio T, Zhou FL, Costello JC; Prostate Cancer Challenge DREAM Community. Guinney J, et al. Among authors: mirtti t. Lancet Oncol. 2017 Jan;18(1):132-142. doi: 10.1016/S1470-2045(16)30560-5. Epub 2016 Nov 16. Lancet Oncol. 2017. PMID: 27864015 Free PMC article. Clinical Trial.

2

Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASP.

Bouslama R, Dumont V, Lindfors S, Paavolainen L, Tienari J, Nisen H, Mirtti T, Saleem MA, Gordin D, Groop PH, Suetsugu S, Lehtonen S. Bouslama R, et al. Among authors: mirtti t. Cells. 2023 May 27;12(11):1487. doi: 10.3390/cells12111487. Cells. 2023. PMID: 37296607 Free PMC article.

3

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.

Saeed K, Rahkama V, Eldfors S, Bychkov D, Mpindi JP, Yadav B, Paavolainen L, Aittokallio T, Heckman C, Wennerberg K, Peehl DM, Horvath P, Mirtti T, Rannikko A, Kallioniemi O, Östling P, Af Hällström TM. Saeed K, et al. Among authors: mirtti t. Eur Urol. 2017 Mar;71(3):319-327. doi: 10.1016/j.eururo.2016.04.019. Epub 2016 May 6. Eur Urol. 2017. PMID: 27160946 Free article.

4

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.

Laajala TD, Seikkula H, Seyednasrollah F, Mirtti T, Boström PJ, Elo LL. Laajala TD, et al. Among authors: mirtti t. Sci Rep. 2016 Nov 2;6:36161. doi: 10.1038/srep36161. Sci Rep. 2016. PMID: 27805011 Free PMC article.

5

Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.

Laajala TD, Seikkula H, Seyednasrollah F, Mirtti T, Boström PJ, Elo LL. Laajala TD, et al. Among authors: mirtti t. Sci Rep. 2017 Jan 19;7:40835. doi: 10.1038/srep40835. Sci Rep. 2017. PMID: 28102298 Free PMC article. No abstract available.

6

Re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40.

Mirtti T, Aittokallio T. Mirtti T, et al. Eur Urol. 2017 Sep;72(3):e68-e69. doi: 10.1016/j.eururo.2017.04.030. Epub 2017 May 9. Eur Urol. 2017. PMID: 28499620 No abstract available.

7

Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study.

Erickson AM, Luzzago S, Semjonow A, Vasarainen H, Laajala TD, Musi G, de Cobelli O, Mirtti T, Rannikko A. Erickson AM, et al. Among authors: mirtti t. Eur Urol Oncol. 2018 Sep;1(4):268-275. doi: 10.1016/j.euo.2018.04.006. Epub 2018 May 15. Eur Urol Oncol. 2018. PMID: 31100247

8

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).

Perez IM, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, Merisaari H, Kiviniemi A, Taimen P, Syvänen KT, Knaapila J, Seppänen M, Rannikko A, Riikonen J, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Boström PJ, Aronen HJ. Perez IM, et al. Among authors: mirtti t. J Magn Reson Imaging. 2020 May;51(5):1556-1567. doi: 10.1002/jmri.26975. Epub 2019 Nov 21. J Magn Reson Imaging. 2020. PMID: 31750988

9

Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets.

Murtojärvi M, Halkola AS, Airola A, Laajala TD, Mirtti T, Aittokallio T, Pahikkala T. Murtojärvi M, et al. Among authors: mirtti t. Int J Med Inform. 2020 Jan;133:104014. doi: 10.1016/j.ijmedinf.2019.104014. Epub 2019 Nov 17. Int J Med Inform. 2020. PMID: 31783311 Free article.

10

OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer.

Halkola AS, Joki K, Mirtti T, Mäkelä MM, Aittokallio T, Laajala TD. Halkola AS, et al. Among authors: mirtti t. PLoS Comput Biol. 2023 Mar 10;19(3):e1010333. doi: 10.1371/journal.pcbi.1010333. eCollection 2023 Mar. PLoS Comput Biol. 2023. PMID: 36897911 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page